Page last updated: 2024-10-28

mephentermine and Ventricular Dysfunction, Left

mephentermine has been researched along with Ventricular Dysfunction, Left in 1 studies

Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Singal, AK1
Deepti, S1
Sharma, G1
Kothari, SS1

Other Studies

1 other study available for mephentermine and Ventricular Dysfunction, Left

ArticleYear
Herculean mistake: mephentermine associated cardiomyopathy.
    The Physician and sportsmedicine, 2021, Volume: 49, Issue:1

    Topics: Adult; Cardiomyopathies; Echocardiography; Embolic Stroke; Humans; Male; Mephentermine; Performance-

2021